Shuttle Pharmaceuticals Holdings Inc (SHPH) Stock Price, Quote & News

Company Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 240 403 4212

Website: www.shuttlepharma.com

Address:

401 Professional Drive, Suite 260, Gaithersburg, United States

StreakGeek Jul. 2 at 5:11 PM

$SHPH $GMM $OPAD change

0 · Reply

twixbarrtwits Jul. 2 at 12:21 PM

$SHPH in 3.55

0 · Reply

topstockalerts Jul. 2 at 11:47 AM

$SHPH keep an eye on it

0 · Reply

AZOZ Jul. 2 at 11:38 AM

$SHPH Insider trading!

0 · Reply

Goldwave9 Jul. 1 at 8:24 PM

$BIYA $WKSP $CDT $SHPH $BTOG Which will bounce back first? Remember, today's dog is tomorrow's greyhound.

1 · Reply

twack999 Jul. 1 at 7:08 PM

$SHPH

0 · Reply

KTGAMBLESTOCKS Jul. 1 at 5:55 PM

$RUM AI data centers take years to build and sometimes encounter local resistance. RUM acquired a bunch which are ready to go. $SHPH $NBIS $CRWV

1 · Reply

Goldwave9 Jul. 1 at 2:02 PM

$SHPH $CDT entering the zone between now and next Thursday where anything can happen any day any hour any minute… literally. Wish I could make it more specific, but nobody hands you money for nothin'

1 · Reply

rac0258 Jul. 1 at 12:29 PM

$LTC.X $SHPH $DOGE.X Another company joining the Scrypt ecosystem to mine Litecoin and Dogecoin.

0 · Reply

Goldwave9 Jun. 30 at 10:02 PM

$SHPH Here's the Secret: all of this price movement today is meaningless

0 · Reply

United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site

Jun 25, 2026, 4:05 PM EDT - 7 days ago

United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting

2026-06-10T23:50:59.000Z - 22 days ago

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

Jun 9, 2026, 8:30 AM EDT - 23 days ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time

May 14, 2026, 4:05 PM EDT - 7 weeks ago

Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

May 7, 2026, 2:02 PM EDT - 2 months ago

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

May 1, 2026, 8:41 AM EDT - 2 months ago

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation

Apr 30, 2026, 4:05 PM EDT - 2 months ago

Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner

Mar 27, 2026, 8:00 AM EDT - 3 months ago

RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 26, 2026, 4:05 PM EDT - 3 months ago

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 12, 2026, 8:30 AM EDT - 4 months ago

E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public Offering

Mar 6, 2026, 8:00 AM EST - 4 months ago

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Jan 13, 2026, 4:00 PM EST - 6 months ago

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Nov 21, 2025, 9:30 AM EST - 7 months ago

Shuttle Pharmaceuticals Acquires AI Health Platform

2025-11-18T22:05:15.000Z - 8 months ago

Shuttle Pharmaceuticals files to sell 625,156 shares of common stock for holders

Nov 3, 2025, 7:00 AM EST - 8 months ago

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Oct 22, 2025, 10:00 AM EDT - 9 months ago

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

Oct 22, 2025, 7:00 AM EDT - 9 months ago

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Oct 21, 2025, 5:55 PM EDT - 9 months ago

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

Oct 21, 2025, 4:05 PM EDT - 9 months ago

Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform

2025-10-10T14:25:15.000Z - 9 months ago

Shuttle Pharmaceuticals announces extension of LOI with Molecule.ai

Oct 10, 2025, 10:20 AM EDT - 9 months ago

Shuttle Executes LOI with Molecule.ai

2025-10-09T20:25:12.000Z - 9 months ago

Shuttle Pharmaceuticals to acquire Molecule.ai for $10M

Oct 9, 2025, 4:15 PM EDT - 9 months ago

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

Aug 14, 2025, 4:05 PM EDT - 11 months ago

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

2025-08-05T10:16:04.000Z - 11 months ago

Shuttle Pharmaceuticals files to sell 1.18M shares of common stock for holders

Jun 24, 2025, 4:10 PM EDT - 1 year ago

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Jun 20, 2025, 3:55 PM EDT - 1 year ago

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

2025-06-13T23:50:22.000Z - 1 year ago

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

2025-06-12T16:05:29.000Z - 1 year ago

Shuttle Pharmaceuticals says reverse stock split to become effective June 16

Jun 12, 2025, 12:00 PM EDT - 1 year ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

2025-06-12T12:45:38.000Z - 1 year ago

Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

Jun 12, 2025, 8:30 AM EDT - 1 year ago

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

2025-06-04T20:10:45.000Z - 1 year ago

Shuttle Pharmaceuticals appoints George Scorsis as chairman

Jun 4, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

2025-05-15T20:50:26.000Z - 1 year ago

Shuttle Pharma Ropidoxuridine Phase 2 trial nears 50% enrollment

May 15, 2025, 4:45 PM EDT - 1 year ago

Shuttle Pharma Provides Corporate Update

May 8, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

Apr 21, 2025, 4:15 PM EDT - 1 year ago

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

2025-04-10T20:10:54.000Z - 1 year ago

Shuttle Pharmaceuticals files provisional patent application with USPTO

Apr 10, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Mar 13, 2025, 4:10 PM EDT - 1 year ago

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

2025-03-12T13:30:38.000Z - 1 year ago

Shuttle Pharmaceuticals prices 19.17M shares at 30c per share in public offering

Mar 12, 2025, 9:24 AM EDT - 1 year ago

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

2025-03-12T10:25:28.000Z - 1 year ago

Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO

Mar 12, 2025, 6:20 AM EDT - 1 year ago

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Feb 26, 2025, 10:45 AM EST - 1 year ago

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

2025-01-21T14:15:45.000Z - 1 year ago

Shuttle reaches milestone in enrollment for Phase 2 trial of Ropidoxuridine

Jan 7, 2025, 9:00 AM EST - 1 year ago

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

2024-12-19T14:11:32.000Z - 1 year ago

Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF

2024-11-26T14:06:10.000Z - 1 year ago

Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line

Nov 26, 2024, 9:00 AM EST - 1 year ago

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Nov 13, 2024, 5:00 PM EST - 1 year ago

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

2024-10-30T01:10:10.000Z - 1 year ago

Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share

Oct 29, 2024, 9:05 PM EDT - 1 year ago

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Oct 28, 2024, 4:05 PM EDT - 1 year ago

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Sep 16, 2024, 9:00 AM EDT - 1 year ago

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Sep 4, 2024, 4:15 PM EDT - 1 year ago

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

Aug 26, 2024, 4:10 PM EDT - 2 years ago

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Aug 14, 2024, 4:10 PM EDT - 2 years ago

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Jul 19, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

Jun 18, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

May 22, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 14, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides First Quarter 2024 Corporate Update

Apr 23, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Apr 3, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Mar 22, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

StreakGeek Jul. 2 at 5:11 PM

$SHPH $GMM $OPAD change

0 · Reply

twixbarrtwits Jul. 2 at 12:21 PM

$SHPH in 3.55

0 · Reply

topstockalerts Jul. 2 at 11:47 AM

$SHPH keep an eye on it

0 · Reply

AZOZ Jul. 2 at 11:38 AM

$SHPH Insider trading!

0 · Reply

Goldwave9 Jul. 1 at 8:24 PM

$BIYA $WKSP $CDT $SHPH $BTOG Which will bounce back first? Remember, today's dog is tomorrow's greyhound.

1 · Reply

twack999 Jul. 1 at 7:08 PM

$SHPH

0 · Reply

KTGAMBLESTOCKS Jul. 1 at 5:55 PM

$RUM AI data centers take years to build and sometimes encounter local resistance. RUM acquired a bunch which are ready to go. $SHPH $NBIS $CRWV

1 · Reply

Goldwave9 Jul. 1 at 2:02 PM

1 · Reply

rac0258 Jul. 1 at 12:29 PM

$LTC.X $SHPH $DOGE.X Another company joining the Scrypt ecosystem to mine Litecoin and Dogecoin.

0 · Reply

Goldwave9 Jun. 30 at 10:02 PM

$SHPH Here's the Secret: all of this price movement today is meaningless

0 · Reply

Zackpedia Jun. 30 at 8:33 PM

$SHPH Down to 3!

0 · Reply

Goldwave9 Jun. 30 at 8:02 PM

$SHPH 30X + float rotation the other day. Somehow, I don't think that was an accident.

0 · Reply

macec Jun. 30 at 1:58 PM

$SHPH oh yeah!

0 · Reply

Goldwave9 Jun. 30 at 10:28 AM

$SHPH $CDT Slowly slowly creeping into position. Where it's situated on the chart matters.

2 · Reply

SooqPulse Jun. 29 at 8:20 PM

$SHPH structural watch. Big spike to 6.88, then the move fully faded and price is now trying to stabilize around the 3.25 area. This is not a clean momentum chart right now — it’s a post-spike fade into base attempt. The key for me: can 3.00–3.25 hold, and can buyers reclaim 3.50 / VWAP area? If that happens with volume, shorts may start paying attention again. If 2.90 fails, the structure weakens and the bleed can continue. Pressure setup only. Risk is high both ways. NFA. DYOR.

1 · Reply

macec Jun. 29 at 5:35 PM

$SHPH where are you?

0 · Reply

Goldwave9 Jun. 29 at 12:57 PM

$SHPH Don't be fooled, it may not be time yet, but this is like a King cobra waiting to strike. And yes, I realize it's in a long-term downtrend but so are most of these other gems lol. Tuesday to Thursday is my timeframe for this.

1 · Reply

Sanjaynaik2011 Jun. 29 at 12:38 PM

$SHPH EVEN AFTER 99.99% DOWN ARE THEY STILL IN THE BUSINESS???

0 · Reply

StockScanners Jun. 27 at 6:12 PM

$SHPH reached 6.38, boom! lets go

0 · Reply

Finding_Five Jun. 27 at 3:29 PM

I've been practicing taking small bites of a big apple, most recently with $SHPH & $AZI after hitting my 5% goal even though they ramped way beyond that. I feel ready for this potentially LIFE CHANGING challenge. Patience + Discipline = Wealth If you made 5% per trade day for 1 year starting with as little as 100 dollars you'd be a multi-millionaire. I'm not an advisor, just someone who realized my greed made me my own worst enemy. Not anymore! I plan to play high-volume situations and be happy with 5% per day. I have LONG TERM goals. Every deep red hole I dug myself started at least 10% up. You wanna spend a year becoming a millionaire with me? WE can do this! Feel free to 'Make a copy' of the Google Sheet I made to track progress. It helps me feel accomplished and affirms my patience. It's free and available under my profile listed as my website. I'll keep posting screenshots of mine so y'all can help keep me honest! 😂 Good luck. Happy hunting.

0 · Reply

DekmarTrades Jun. 27 at 12:28 AM

As slow as this week has been, I have been trading extremely well! $PBK $QUCY $SDOT $SHPH $WEN Let me explain my entire strategy: 1. Trading in Pre Market means no halts/manipulation 2. Only trade during the hot "Press Release Waves" 3. News= Spikes. Either be in right when news is released or short the top. 4. Commit to your trade. If you are buying, have confidence to buy and hold for a profit. If you are Shorting enter and stick to your plan. At the end of the day my motto is, if you arent in first look to Short. We know all these sub $25 stocks spike and crash right back down. Either ride the 100% wave or Short it after the 100% climb.

1 · Reply

DayTrade_4Life Jun. 27 at 12:09 AM

💪From the Watchlist & Alerts Today 26 June 26: 👉See Profile and link there to Join Us. $SDOT: 10 to 25.57 (155%) $UPC: 7 to 12.25 (75%) Member called it in chat but I’m still claiming it. I helped w/some levels. LOL. $IVF: 2 to 3.08 (54%) $RCT: .40 to .51 (27%) $SHPH: 5.10 to 6.25 (22%) HKIT: .33 .37 (12%)

2 · Reply

Market Cap	2.17M
Revenue (ttm)	0.00
Net Income (ttm)	-11.72M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	199,600
Avg Vol	1,048,671
Day's Range	N/A - N/A
Shares Out	637,000.00
Stochastic %K	21%
Beta	0.29
Analysts	Strong Buy
Price Target	N/A